ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
日本語
MicroRNAs in Alzheimer's disease: Early diagnosis and progression monitoring through mitochondrial dysfunction insights | Synapse
March 3, 2026
MicroRNAs in Alzheimer's disease: Early diagnosis and progression monitoring through mitochondrial dysfunction insights
JA
Joshua Annamalai
DP
Dilan Sathi prakasan
Tbilisi State Medical University
NN
Nishanth Rahal Nadesan
See all
Key Points
Early diagnosis of Alzheimer's disease may be improved through microrna insights related to mitochondrial dysfunction.
Key findings suggest that specific micrornas are linked to the progression of Alzheimer's in diagnosed individuals.
Assessment using microrna profiling makes mitochondrial dysfunction measurable in relation to disease progression.
Results highlight the potential for micrornas to serve as diagnostic tools, but further validation in larger cohorts is necessary.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Annamalai et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75e88c6e9836116a29388
https://doi.org/https://doi.org/10.1016/j.jns.2025.125348